Received government funding or funding expected in current financial year
No
Business Relationships
Innovative Medicines Canada/Médicaments Novateurs Canada is not a subsidiary of any other parent companies.
Innovative Medicines Canada/Médicaments Novateurs Canada is not a coalition.
Beneficiaries of the Lobbying Activity
The activities of Innovative Medicines Canada/Médicaments Novateurs Canada are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Innovative Medicines Canada/Médicaments Novateurs Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
What is being lobbied?
Subject Matters
Consumer Issues
Health
Research and Development
Subject Matter Details
Regulation
IMC will be conducting a digital campaign to engage constituents in key electoral regions who are concerned about access to medicines, vaccines and COVID-19.
Who is being lobbied?
Government Institutions
House of Commons
Communication techniques
Communication techniques that have been used or are expected to be used in the course of the undertaking: